This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXMPEA6606G_M.jpg
The company’s prior IPO filing took place in October 2021 and received Sebi’s approval in January 2022 for a size of approximately Rs 500 crore. GPT Sons, the promoter, currently holds a significant majority stake of 67.34% in the hospital chain, which operates under the ILS Hospitals brand. The remaining shares are held by BanyanTree Growth Capital.
The healthcare provider intends to allocate Rs 30 crore from the IPO proceeds towards debt repayment, with the remaining funds to be utilized for corporate purposes. Operating four mid-sized full-service hospitals with a total capacity of 561 beds, GPT Healthcare reported revenue of Rs 361 crore and a profit growth rate of 36% during the FY21-FY23 period.
JM Financial is acting as the merchant banker for this IPO, while Link Intime India is serving as the registrar.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
